{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T14:03:02Z","timestamp":1785333782428,"version":"3.55.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009057","name":"University of Graz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009057","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Doxorubicin is an effective cancer chemotherapeutic, but its use is complicated by cardiotoxic side-effects. 5-amino-4-imidazolecarboxamide ribonucleoside (AICAr) is a widely used pharmacological activator of adenosine monophosphate-activated kinase (AMPK), but also exerts AMPK-independent actions that may have unrealized therapeutic potential. Here, we identified a novel mechanism by which pretreatment with AICAr protects neonatal rat cardiomyocytes against doxorubicin toxicity. Despite increasing AMPK\n                    <jats:sup>Thr172<\/jats:sup>\n                    and ULK1\n                    <jats:sup>Ser555<\/jats:sup>\n                    phosphorylation, AICAr suppressed cardiomyocyte LC3 lipidation and caused accumulation of the autophagy receptor, p62 SQST1, through an adenosine kinase (ADK)-dependent, AMPK-independent mechanism. The accumulation of p62 was associated with increased expression and transcriptional activity of NRF2, as well as decreased doxorubicin-induced reactive oxygen species and cell death. Notably, AICAr-induced increase of NRF2, antioxidant gene expression, and doxorubicin resistance were blocked by RNAi depletion of p62, indicating that the protective effects of AICAr rely upon the secondary effects of autophagy inhibition, rather than autophagy inhibition per se. While doxorubicin treatment alone did not affect cardiomyocyte LC3 lipidation, it did significantly decrease p62 levels and diminish NRF2 nuclear localization. Pretreatment with AICAr to provide surplus p62 and nuclear NRF2 diminished the impact of these doxorubicin effects. Importantly, MCF7 breast cancer cells, which poorly express ADK, were not protected by AICAr pretreatment and instead were sensitized to doxorubicin-induced cell death. These findings raise the possibility that differences in ADK expression between cardiomyocytes and breast cancer cells might be exploited by pretreatment with AICAr or similar ADK-dependent drugs to provide dual benefits in doxorubicin therapy.\n                  <\/jats:p>","DOI":"10.1007\/s00018-025-05905-4","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T04:35:32Z","timestamp":1763008532000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["AICAr Inhibition of cardiomyocyte autophagy promotes p62-dependent NRF2 expression and protection against doxorubicin toxicity"],"prefix":"10.1007","volume":"82","author":[{"given":"Erin K.","family":"Fassett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4591-6875","authenticated-orcid":false,"given":"John T.","family":"Fassett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"5905_CR1","unstructured":"Johnson-Arbor K, Dubey R Doxorubicin. [updated 2023 Aug 8]. StatPearls. Treasure Island (FL) Statpearl Publishing 2025 Jan"},{"key":"5905_CR2","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/s0006-2952(98)00307-4","volume":"57","author":"DA Gewirtz","year":"1999","unstructured":"Gewirtz DA (1999) A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 57:727\u2013741. https:\/\/doi.org\/10.1016\/s0006-2952(98)00307-4","journal-title":"Biochem Pharmacol"},{"key":"5905_CR3","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5381692","volume":"2019","author":"SJ Kim","year":"2019","unstructured":"Kim SJ, Kim HS, Seo YR (2019) Understanding of ROS-inducing strategy in anticancer therapy. Oxid Med Cell Longev 2019:5381692. https:\/\/doi.org\/10.1155\/2019\/5381692","journal-title":"Oxid Med Cell Longev"},{"key":"5905_CR4","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.1200\/JCO.2007.14.9401","volume":"26","author":"L Gianni","year":"2008","unstructured":"Gianni L, Herman EH, Lipshultz SE, Minotti G, Sarvazyan N, Sawyer DB (2008) Anthracycline cardiotoxicity: from bench to bedside. J Clin Oncol 26:3777\u20133784. https:\/\/doi.org\/10.1200\/JCO.2007.14.9401","journal-title":"J Clin Oncol"},{"key":"5905_CR5","doi-asserted-by":"publisher","first-page":"839644","DOI":"10.3389\/fcvm.2022.839644","volume":"9","author":"M Singh","year":"2022","unstructured":"Singh M, Nicol AT, DelPozzo J, Wei J, Singh M, Nguyen T, Kobayashi S, Liang Q (2022) Demystifying the relationship between metformin, AMPK, and doxorubicin cardiotoxicity. Front Cardiovasc Med 9:839644. https:\/\/doi.org\/10.3389\/fcvm.2022.839644","journal-title":"Front Cardiovasc Med"},{"key":"5905_CR6","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7176282","volume":"2022","author":"G Ling","year":"2022","unstructured":"Ling G, Wang X, Tan N, Cao J, Li W, Zhang Y, Jiang J, Sun Q, Jiang Y, Wang W, Wang Y (2022) Mechanisms and drug intervention for doxorubicin-induced cardiotoxicity based on mitochondrial bioenergetics. Oxid Med Cell Longev 2022:7176282. https:\/\/doi.org\/10.1155\/2022\/7176282","journal-title":"Oxid Med Cell Longev"},{"key":"5905_CR7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41420-023-01565-0","volume":"9","author":"X Zhao","year":"2023","unstructured":"Zhao X, Tian Z, Sun M, Dong D (2023) Nrf2: a dark horse in doxorubicin-induced cardiotoxicity. Cell Death Discov 9:261. https:\/\/doi.org\/10.1038\/s41420-023-01565-0","journal-title":"Cell Death Discov"},{"key":"5905_CR8","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00099-20","author":"L Baird","year":"2020","unstructured":"Baird L, Yamamoto M (2020) The molecular mechanisms regulating the KEAP1-NRF2 pathway. Mol Cell Biol. https:\/\/doi.org\/10.1128\/MCB.00099-20","journal-title":"Mol Cell Biol"},{"key":"5905_CR9","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1152\/physrev.00023.2017","volume":"98","author":"M Yamamoto","year":"2018","unstructured":"Yamamoto M, Kensler TW, Motohashi H (2018) The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis. Physiol Rev 98:1169\u20131203. https:\/\/doi.org\/10.1152\/physrev.00023.2017","journal-title":"Physiol Rev"},{"key":"5905_CR10","doi-asserted-by":"publisher","first-page":"748524","DOI":"10.1155\/2014\/748524","volume":"2014","author":"S Li","year":"2014","unstructured":"Li S, Wang W, Niu T, Wang H, Li B, Shao L, Lai Y, Li H, Janicki JS, Wang XL, Tang D, Cui T (2014) Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunction. Oxid Med Cell Longev 2014:748524. https:\/\/doi.org\/10.1155\/2014\/748524","journal-title":"Oxid Med Cell Longev"},{"key":"5905_CR11","doi-asserted-by":"publisher","first-page":"6034","DOI":"10.1111\/jcmm.14466","volume":"23","author":"H Lin","year":"2019","unstructured":"Lin H, Zhang J, Ni T, Lin N, Meng L, Gao F, Luo H, Liu X, Chi J, Guo H (2019) Yellow wine polyphenolic compounds prevents doxorubicin-induced cardiotoxicity through activation of the Nrf2 signalling pathway. J Cell Mol Med 23:6034\u20136047. https:\/\/doi.org\/10.1111\/jcmm.14466","journal-title":"J Cell Mol Med"},{"key":"5905_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/ncb2021","volume":"12","author":"M Komatsu","year":"2010","unstructured":"Komatsu M, Kurokawa H, Waguri S, Taguchi K, Kobayashi A, Ichimura Y, Sou YS, Ueno I, Sakamoto A, Tong KI, Kim M, Nishito Y, Iemura S, Natsume T, Ueno T, Kominami E, Motohashi H, Tanaka K, Yamamoto M (2010) The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol 12:213\u2013223. https:\/\/doi.org\/10.1038\/ncb2021","journal-title":"Nat Cell Biol"},{"key":"5905_CR13","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1080\/15548627.2020.1712108","volume":"16","author":"DH Lee","year":"2020","unstructured":"Lee DH, Park JS, Lee YS, Han J, Lee D-K, Kwon SW, Han DH, Lee Y-H, Bae SH (2020) SQSTM1\/p62 activates NFE2L2\/NRF2 via ULK1-mediated autophagic KEAP1 degradation and protects mouse liver from lipotoxicity. Autophagy 16:1949\u20131973. https:\/\/doi.org\/10.1080\/15548627.2020.1712108","journal-title":"Autophagy"},{"key":"5905_CR14","doi-asserted-by":"publisher","first-page":"22576","DOI":"10.1074\/jbc.M110.118976","volume":"285","author":"A Jain","year":"2010","unstructured":"Jain A, Lamark T, Sjottem E, Larsen KB, Awuh JA, Overvatn A, McMahon M, Hayes JD, Johansen T (2010) p62\/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J Biol Chem 285:22576\u201322591. https:\/\/doi.org\/10.1074\/jbc.M110.118976","journal-title":"J Biol Chem"},{"key":"5905_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.freeradbiomed.2015.06.014","volume":"88","author":"T Jiang","year":"2015","unstructured":"Jiang T, Harder B, Rojo de la Vega M, Wong PK, Chapman E, Zhang DD (2015) p62 links autophagy and Nrf2 signaling. Free Radic Biol Med 88:199\u2013204. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2015.06.014","journal-title":"Free Radic Biol Med"},{"key":"5905_CR16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.freeradbiomed.2023.06.004","volume":"205","author":"HH Liao","year":"2023","unstructured":"Liao HH, Ding W, Zhang N, Zhou ZY, Ling Z, Li WJ, Chen S, Tang QZ (2023) Activation of AMPK\u03b12 attenuated doxorubicin-induced cardiotoxicity via inhibiting lipid peroxidation associated ferroptosis. Free Radic Biol Med 205:275\u2013290. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.06.004","journal-title":"Free Radic Biol Med"},{"key":"5905_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10557-020-06941-x","volume":"34","author":"KN Timm","year":"2020","unstructured":"Timm KN, Tyler DJ (2020) The role of AMPK activation for cardioprotection in doxorubicin-induced cardiotoxicity. Cardiovasc Drugs Ther 34:255\u2013269. https:\/\/doi.org\/10.1007\/s10557-020-06941-x","journal-title":"Cardiovasc Drugs Ther"},{"key":"5905_CR18","doi-asserted-by":"publisher","first-page":"12759","DOI":"10.1038\/s41598-023-40061-4","volume":"13","author":"N Osataphan","year":"2023","unstructured":"Osataphan N, Phrommintikul A, Leemasawat K, Somwangprasert A, Apaijai N, Suksai S, Sirikul W, Gunaparn S, Chattipakorn SC, Chattipakorn N (2023) Effects of metformin and donepezil on the prevention of doxorubicin-induced cardiotoxicity in breast cancer: a randomized controlled trial. Sci Rep 13:12759. https:\/\/doi.org\/10.1038\/s41598-023-40061-4","journal-title":"Sci Rep"},{"key":"5905_CR19","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1432-1033.1995.tb20498.x","volume":"229","author":"JM Corton","year":"1995","unstructured":"Corton JM, Gillespie JG, Hawley SA, Hardie DG (1995) 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem \/ FEBS 229:558\u2013565. https:\/\/doi.org\/10.1111\/j.1432-1033.1995.tb20498.x","journal-title":"Eur J Biochem \/ FEBS"},{"key":"5905_CR20","doi-asserted-by":"publisher","unstructured":"Visnjic D, Lalic H, Dembitz V, Tomic B, Smoljo T (2021) AICAr, a widely used AMPK activator with important AMPK-Independent effects: A systematic review. Cells 10. https:\/\/doi.org\/10.3390\/cells10051095","DOI":"10.3390\/cells10051095"},{"key":"5905_CR21","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.212969","author":"T Israeli","year":"2018","unstructured":"Israeli T, Riahi Y, Saada A, Yefet D, Cerasi E, Tirosh B, Leibowitz G (2018) Opposing effects of intracellular versus extracellular adenine nucleotides on autophagy: implications for \u03b2-cell function. J Cell Sci. https:\/\/doi.org\/10.1242\/jcs.212969","journal-title":"J Cell Sci"},{"key":"5905_CR22","doi-asserted-by":"publisher","first-page":"23758","DOI":"10.1074\/jbc.273.37.23758","volume":"273","author":"HR Samari","year":"1998","unstructured":"Samari HR, Seglen PO (1998) Inhibition of hepatocytic autophagy by adenosine, aminoimidazole-4-carboxamide riboside, and N6-mercaptopurine riboside. Evidence for involvement of amp-activated protein kinase. J Biol Chem 273:23758\u201323763","journal-title":"J Biol Chem"},{"key":"5905_CR23","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.bbrc.2008.02.126","volume":"369","author":"R Viana","year":"2008","unstructured":"Viana R, Aguado C, Esteban I, Moreno D, Viollet B, Knecht E, Sanz P (2008) Role of AMP-activated protein kinase in autophagy and proteasome function. Biochem Biophys Res Commun 369:964\u2013968. https:\/\/doi.org\/10.1016\/j.bbrc.2008.02.126","journal-title":"Biochem Biophys Res Commun"},{"key":"5905_CR24","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/jcbfm.2010.220","volume":"31","author":"C Kilkenny","year":"2011","unstructured":"Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, National Centre for the, Replacement R, Reduction of Amimals in R (2011) Animal research: reporting in vivo experiments\u2013the ARRIVE guidelines. J Cereb Blood Flow Metab 31:991\u2013993. https:\/\/doi.org\/10.1038\/jcbfm.2010.220","journal-title":"J Cereb Blood Flow Metab"},{"key":"5905_CR25","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1111\/j.1476-5381.2010.00873.x","volume":"160","author":"JC McGrath","year":"2010","unstructured":"McGrath JC, Drummond GB, McLachlan EM, Kilkenny C, Wainwright CL (2010) Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160:1573\u20131576. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00873.x","journal-title":"Br J Pharmacol"},{"key":"5905_CR26","doi-asserted-by":"publisher","first-page":"H523","DOI":"10.1152\/ajpheart.00462.2009","volume":"297","author":"JT Fassett","year":"2009","unstructured":"Fassett JT, Xu X, Hu X, Zhu G, French J, Chen Y, Bache RJ (2009) Adenosine regulation of microtubule dynamics in cardiac hypertrophy. Am J Physiol Heart Circ Physiol 297:H523\u2013532 doi:00462.2009 [pii]","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"5905_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073887","volume":"8","author":"JT Fassett","year":"2013","unstructured":"Fassett JT, Xu X, Kwak D, Wang H, Liu X, Hu X, Bache RJ, Chen Y (2013) Microtubule actin cross-linking factor 1 regulates cardiomyocyte microtubule distribution and adaptation to hemodynamic overload. PLoS ONE 8:e73887","journal-title":"PLoS ONE"},{"key":"5905_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41467-021-27732-4","volume":"13","author":"G Grigolon","year":"2022","unstructured":"Grigolon G, Araldi E, Erni R, Wu JY, Thomas C, La Fortezza M, Laube B, P\u00f6hlmann D, Stoffel M, Zarse K, Carreira EM, Ristow M, Fischer F (2022) Grainyhead 1 acts as a drug-inducible conserved transcriptional regulator linked to insulin signaling and lifespan. Nat Commun 13:107. https:\/\/doi.org\/10.1038\/s41467-021-27732-4","journal-title":"Nat Commun"},{"key":"5905_CR29","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/s41588-018-0204-y","volume":"50","author":"AO Giacomelli","year":"2018","unstructured":"Giacomelli AO, Yang X, Lintner RE, McFarland JM, Duby M, Kim J, Howard TP, Takeda DY, Ly SH, Kim E, Gannon HS, Hurhula B, Sharpe T, Goodale A, Fritchman B, Steelman S, Vazquez F, Tsherniak A, Aguirre AJ, Doench JG, Piccioni F, Roberts CWM, Meyerson M, Getz G, Johannessen CM, Root DE, Hahn WC (2018) Mutational processes shape the landscape of TP53 mutations in human cancer. Nat Genet 50:1381\u20131387. https:\/\/doi.org\/10.1038\/s41588-018-0204-y","journal-title":"Nat Genet"},{"key":"5905_CR30","doi-asserted-by":"publisher","unstructured":"Strober W (2015) Trypan blue exclusion test of cell viability. Curr Protoc Immunol 111(A3 B 1\u2013A3 B 3). https:\/\/doi.org\/10.1002\/0471142735.ima03bs111","DOI":"10.1002\/0471142735.ima03bs111"},{"key":"5905_CR31","doi-asserted-by":"publisher","first-page":"9145","DOI":"10.1080\/21655979.2022.2036895","volume":"13","author":"Z Lu","year":"2022","unstructured":"Lu Z, Liu Z, Fang B (2022) Propofol protects cardiomyocytes from doxorubicin-induced toxic injury by activating the nuclear factor erythroid 2-related factor 2\/glutathione peroxidase 4 signaling pathways. Bioengineered 13:9145\u20139155. https:\/\/doi.org\/10.1080\/21655979.2022.2036895","journal-title":"Bioengineered"},{"key":"5905_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/795602","volume":"2015","author":"P Angsutararux","year":"2015","unstructured":"Angsutararux P, Luanpitpong S, Issaragrisil S (2015) Chemotherapy-induced cardiotoxicity: overview of the roles of oxidative stress. Oxid Med Cell Longev 2015:795602. https:\/\/doi.org\/10.1155\/2015\/795602","journal-title":"Oxid Med Cell Longev"},{"key":"5905_CR33","first-page":"312","volume":"8","author":"R Li","year":"2019","unstructured":"Li R, Jia Z, Zhu H (2019) Regulation of Nrf2 signaling. React Oxyg Species 8:312\u2013322","journal-title":"React Oxyg Species (Apex)"},{"key":"5905_CR34","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1038\/s41467-023-38401-z","volume":"14","author":"JM Park","year":"2023","unstructured":"Park JM, Lee DH, Kim DH (2023) Redefining the role of AMPK in autophagy and the energy stress response. Nat Commun 14:2994. https:\/\/doi.org\/10.1038\/s41467-023-38401-z","journal-title":"Nat Commun"},{"key":"5905_CR35","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1074\/jbc.M109.070037","volume":"285","author":"S Kobayashi","year":"2010","unstructured":"Kobayashi S, Volden P, Timm D, Mao K, Xu X, Liang Q (2010) Transcription factor GATA4 inhibits doxorubicin-induced autophagy and cardiomyocyte death. J Biol Chem 285:793\u2013804. https:\/\/doi.org\/10.1074\/jbc.M109.070037","journal-title":"J Biol Chem"},{"key":"5905_CR36","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.bcp.2012.10.005","volume":"85","author":"BJ Sishi","year":"2013","unstructured":"Sishi BJ, Loos B, van Rooyen J, Engelbrecht AM (2013) Autophagy upregulation promotes survival and attenuates doxorubicin-induced cardiotoxicity. Biochem Pharmacol 85:124\u2013134. https:\/\/doi.org\/10.1016\/j.bcp.2012.10.005","journal-title":"Biochem Pharmacol"},{"key":"5905_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.yjmcc.2024.04.011","volume":"191","author":"A Choksey","year":"2024","unstructured":"Choksey A, Carter RD, Thackray BD, Ball V, Kennedy BWC, Ha LHT, Sharma E, Broxholme J, Castro-Guarda M, Murphy MP, Heather LC, Tyler DJ, Timm KN (2024) AICAR confers prophylactic cardioprotection in doxorubicin-induced heart failure in rats. J Mol Cell Cardiol 191:12\u201322. https:\/\/doi.org\/10.1016\/j.yjmcc.2024.04.011","journal-title":"J Mol Cell Cardiol"},{"key":"5905_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/s10565-023-09831-8","author":"X Sun","year":"2023","unstructured":"Sun X, Du J, Meng H, Liu F, Yang N, Deng S, Wan H, Ye D, Song E, Zeng H (2023) Targeting autophagy with SAR405 alleviates doxorubicin-induced cardiotoxicity. Cell Biol Toxicol. https:\/\/doi.org\/10.1007\/s10565-023-09831-8","journal-title":"Cell Biol Toxicol"},{"key":"5905_CR39","doi-asserted-by":"publisher","first-page":"153512","DOI":"10.1016\/j.tox.2023.153512","volume":"490","author":"X Sun","year":"2023","unstructured":"Sun X, Meng H, Xiao J, Liu F, Du J, Zeng H (2023) Pretreatment of 3-MA prevents doxorubicin-induced cardiotoxicity through inhibition of autophagy initiation. Toxicology 490:153512. https:\/\/doi.org\/10.1016\/j.tox.2023.153512","journal-title":"Toxicology"},{"key":"5905_CR40","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.freeradbiomed.2022.07.014","volume":"190","author":"E Petsouki","year":"2022","unstructured":"Petsouki E, Cabrera SNS, Heiss EH (2022) AMPK and NRF2: interactive players in the same team for cellular homeostasis? Free Radic Biol Med 190:75\u201393. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.07.014","journal-title":"Free Radic Biol Med"},{"key":"5905_CR41","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1128\/mcb.00118-16","volume":"36","author":"MS Joo","year":"2016","unstructured":"Joo MS, Kim WD, Lee KY, Kim JH, Koo JH, Kim SG (2016) AMPK facilitates nuclear accumulation of Nrf2 by phosphorylating at serine 550. Mol Cell Biol 36:1931\u20131942. https:\/\/doi.org\/10.1128\/mcb.00118-16","journal-title":"Mol Cell Biol"},{"key":"5905_CR42","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1080\/15548627.2016.1208889","volume":"12","author":"M Pajares","year":"2016","unstructured":"Pajares M, Jim\u00e9nez-Moreno N, Garc\u00eda-Yag\u00fce \u00c1J, Escoll M, de Ceballos ML, Van Leuven F, R\u00e1bano A, Yamamoto M, Rojo AI, Cuadrado A (2016) Transcription factor NFE2L2\/NRF2 is a regulator of macroautophagy genes. Autophagy 12:1902\u20131916. https:\/\/doi.org\/10.1080\/15548627.2016.1208889","journal-title":"Autophagy"},{"key":"5905_CR43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2217425120","volume":"120","author":"AJS Ong","year":"2023","unstructured":"Ong AJS, Bladen CE, Tigani TA, Karamalakis AP, Evason KJ, Brown KK, Cox AG (2023) The KEAP1-NRF2 pathway regulates TFEB\/TFE3-dependent lysosomal biogenesis. Proc Natl Acad Sci U S A 120:e2217425120. https:\/\/doi.org\/10.1073\/pnas.2217425120","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5905_CR44","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1080\/15548627.2021.1898748","volume":"17","author":"M Paquette","year":"2021","unstructured":"Paquette M, El-Houjeiri L, L CZ, Puustinen P, Blanchette P, Jeong H, Dejgaard K, Siegel PM, Pause A (2021) AMPK-dependent phosphorylation is required for transcriptional activation of TFEB and TFE3. Autophagy 17:3957\u20133975. https:\/\/doi.org\/10.1080\/15548627.2021.1898748","journal-title":"Autophagy"},{"key":"5905_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yjmcc.2017.01.007","volume":"104","author":"JJ Bartlett","year":"2017","unstructured":"Bartlett JJ, Trivedi PC, Pulinilkunnil T (2017) Autophagic dysregulation in doxorubicin cardiomyopathy. J Mol Cell Cardiol 104:1\u20138. https:\/\/doi.org\/10.1016\/j.yjmcc.2017.01.007","journal-title":"J Mol Cell Cardiol"},{"key":"5905_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.176180","volume":"961","author":"A Aikawa","year":"2023","unstructured":"Aikawa A, Kozako T, Kato N, Ohsugi T, Honda SI (2023) Anti-tumor activity of 5-aminoimidazole-4-carboxamide riboside with AMPK-independent cell death in human adult T-cell leukemia\/lymphoma. Eur J Pharmacol 961:176180. https:\/\/doi.org\/10.1016\/j.ejphar.2023.176180","journal-title":"Eur J Pharmacol"},{"key":"5905_CR47","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.1182\/blood-2002-07-2339","volume":"101","author":"C Camp\u00e0s","year":"2003","unstructured":"Camp\u00e0s C, Lopez JM, Santidri\u00e1n AF, Barrag\u00e1n M, Bellosillo B, Colomer D, Gil J (2003) Acadesine activates AMPK and induces apoptosis in B-cell chronic lymphocytic leukemia cells but not in T lymphocytes. Blood 101:3674\u20133680. https:\/\/doi.org\/10.1182\/blood-2002-07-2339","journal-title":"Blood"},{"key":"5905_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215659","volume":"535","author":"L Ghiraldeli","year":"2022","unstructured":"Ghiraldeli L, Anderson R, Pladna K, Pardee TS (2022) Adenosine monophosphate activated protein kinase (AMPK) enhances chemotherapy response in acute myeloid leukemia (AML). Cancer Lett 535:215659. https:\/\/doi.org\/10.1016\/j.canlet.2022.215659","journal-title":"Cancer Lett"},{"key":"5905_CR49","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.bcp.2014.07.010","volume":"91","author":"B Sid","year":"2014","unstructured":"Sid B, Glorieux C, Valenzuela M, Rommelaere G, Najimi M, Dejeans N, Renard P, Verrax J, Calderon PB (2014) AICAR induces Nrf2 activation by an AMPK-independent mechanism in hepatocarcinoma cells. Biochem Pharmacol 91:168\u2013180. https:\/\/doi.org\/10.1016\/j.bcp.2014.07.010","journal-title":"Biochem Pharmacol"},{"key":"5905_CR50","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00280-012-2033-5","volume":"71","author":"E Van Den Neste","year":"2013","unstructured":"Van Den Neste E, Cazin B, Janssens A, Gonz\u00e1lez-Barca E, Terol MJ, Levy V, P\u00e9rez de Oteyza J, Zachee P, Saunders A, de Frias M, Camp\u00e0s C (2013) Acadesine for patients with relapsed\/refractory chronic lymphocytic leukemia (CLL): a multicenter phase I\/II study. Cancer Chemother Pharmacol 71:581\u2013591. https:\/\/doi.org\/10.1007\/s00280-012-2033-5","journal-title":"Cancer Chemother Pharmacol"},{"key":"5905_CR51","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jacc.2006.04.044","volume":"48","author":"DT Mangano","year":"2006","unstructured":"Mangano DT, Miao Y, Tudor IC, Dietzel C (2006) Post-reperfusion myocardial infarction: long-term survival improvement using adenosine regulation with Acadesine. J Am Coll Cardiol 48:206\u2013214. https:\/\/doi.org\/10.1016\/j.jacc.2006.04.044","journal-title":"J Am Coll Cardiol"},{"key":"5905_CR52","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1001\/jama.2012.7633","volume":"308","author":"MF Newman","year":"2012","unstructured":"Newman MF, Ferguson TB, White JA, Ambrosio G, Koglin J, Nussmeier NA, Pearl RG, Pitt B, Wechsler AS, Weisel RD, Reece TL, Lira A, Harrington RA (2012) Effect of adenosine-regulating agent Acadesine on morbidity and mortality associated with coronary artery bypass grafting: the RED-CABG randomized controlled trial. JAMA 308:157\u2013164. https:\/\/doi.org\/10.1001\/jama.2012.7633","journal-title":"JAMA"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05905-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-025-05905-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05905-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:57:22Z","timestamp":1781614642000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-025-05905-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5905"],"URL":"https:\/\/doi.org\/10.1007\/s00018-025-05905-4","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"30 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised due to incorrect placement of figure 8 in PubMed. Now, it has been Corrected.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing financial or non-financial interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"395"}}